Cancer treatment as a game: Integrating evolutionary game theory into the optimal control of chemotherapy

Physical Biology

Volumn 9, Issue 6, 2012, Pages

  Orlando, Paul A ^a   Gatenby, Robert A ^b   Brown, Joel S ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BIOLOGICAL MODEL; DRUG RESISTANCE; EVOLUTION; GAME; HUMAN; NEOPLASM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; BIOLOGICAL EVOLUTION; DRUG RESISTANCE, NEOPLASM; GAME THEORY; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 84871218217     PISSN: 14783967     EISSN: 14783975     Source Type: Journal    
DOI: 10.1088/1478-3975/9/6/065007     Document Type: Review

References (16)

1. Antonia S J et al 2006 Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer Clin. Cancer Res. 12 878-87
2. Beijnen J H and Schellens J H M 2004 Drug interactions in oncology Lancet Oncol. 5 489-96
3. Brown J S 1992 Patch use under predation risk: I. Models and predictions Ann. Zool. Fenn. 29 301-9
4. Brown J S and Kotler B P 2004 Hazardous duty pay and the foraging cost of predation Ecol. Lett. 7 999-1014
5. Cunningham J J, Gatenby R A and Brown J S 2011 Evolutionary dynamics in cancer therapy Mol. Pharm. 8 2094-100
6. Engelhart M, Lebiedz D and Sager S 2011 Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function Math. Biosci. 229 123-34
7. Gatenby R A, Brown J S and Vincent T L 2009 Lessons from applied ecology: cancer control using an evolutionary double bind Cancer Res. 69 7499-502
8. Gatenby R A and Vincent T L 2003 An evolutionary model of carcinogenesis Cancer Res. 63 6212-20
9. Gottesman M M 2002 Mechanisms of cancer drug resistance Annu. Rev. Med. 53 615-27
10. Ledzewicz U and Schattler H 2006 Drug resistance in cancer chemotherapy as an optimal control problem Discrete Contin. Dyn. B 6 129-50
11. Rao A V, Benson D A, Darby C, Patterson M A, Francolin C, Sanders I and Huntington G T 2010 Algorithm 902: GPOPS, a MATLAB software for solving multiple-phase optimal control problems using the gauss pseudospectral method ACM Trans. Math. Softw. 37 22:1-22:39
12. Riechelmann R P and Del Giglio A 2009 Drug interaction in oncology: how common are they? Ann. Oncol. 20 1907-12
13. Vasi F K and Lenski R E 1999 Ecological strategies and fitness tradeoffs in Escherichia Coli mutants adapted to prolonged starvation J. Genet. 78 43-9
14. Vincent T L and Brown J S 2005 Evolutionary Game Theory, Natural Selection, and Darwinian Dynamics (Cambridge: Cambridge University Press)
15. Vincent T L and Gatenby R A 2008 An evolutionary model for initiation, promotion, and progression in carcinogenesis Int. J. Oncol. 32 729-37
16. Vogel C L et al 2002 Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER-2-overexpressing metastatic breast cancer J. Clin. Oncol. 20 719-26